käed -
gene1 gene2
- - -
gene Sept.13-15,2001
- - - -
- -
overview -
programme -
speakers -
registration -
links -
estonia -
eesti keeles -
main page

main sponsor
organized by
Eesti Geenikeskus
scientific programme committee
Prof. Andres Metspalu
University of Tartu, Estonia
Dr. Jaanus Pikani
Estonian Genome Foundation, Estonia

Esonian Biocentre
tartu - city of good thoughts
tartu ülikool

Registration at the Vanemuine Concert Hall
18:45-19:00 OPENING of the FORUM
Prof. Peeter Tulviste, Chairman of the Tartu City Council
Former Rector Magnificus of The University of Tartu, Estonia
Prof. Klaus Lindpaintner
Vice President and Director, Roche Genetics, 
F. Hoffmann-La Roche AG, Switzerland 
"Impact of Genetics and Genomics on Health Care: Opportunities and Challenges"
Welcome Reception
Friday, Sept 14, 2001
9:00-11:00 SESSION I
Dr. Andreas Braun
Chief Medical Officer, Sequenom Inc., USA 
"From SNPs to Medical Utility" 
Dr. Roger B Derbyshire
Associate Director, Orchid BioSciences Europe Ltd, UK
"Large Scale SNP Genotyping using Primer Extension on Multiple Platforms: Determination of Genome Wide SNP Allele Frequency Map"
Mr. Stanford (Ford) N. Goldman, Jr.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., USA
"Capital Formation: From Start-up to IPO, The American Experience"
Coffee/tea break
11:20-13:20 SESSION II
Dr. Ian Dunham
Sanger Centre, Hinxton, Cambridge, UK 
"The Human Genome Project" 
Dr. Wojciech Makalowski
Department of Biology and Institute of Molecular Evolutionary Genetics, Pennsylvania State University, Pennsylvania, USA 
"Computational Genomics - Promises and Challenges" 
Dr. Olli-P. Kallioniemi
National Human Genome Research Institute, National Institutes of Health, Bethesda, USA 
"Biochip Technologies in Cancer Research: From Genome Screening to Identification of Therapeutic Targets"
14:30-15:40 SESSION III
Dr. Mark S. Chee, Vice President of Genomics, Illumina Inc., USA 
"Accessing Genetic Information: Technology for Large Scale SNP Genotyping"
Dr. Richard Grosse, CEO, InGene, Germany
"PHENOMETM: The Clinical Database for Phenotype Driven Genotyping"
Coffee/tea break
16:00-17:40 SESSION IV
Prof. Andres Metspalu
Department of Biotechnology, University of Tartu, Estonia 
"Estonian Genome Project: Current Status, Permissive Technologies and Future Steps" 
Dr. Kalev Kask
Stanford University, USA 
"Estonian Genome Project: From Candidate Genes to Personalized Medicine" 
Prof. Gisli Palsson, Director and Professor, Institute of Anthropology, University of Iceland, Iceland 
"For Whom the Cells Toll: Debates About Biomedicine"
Buffet Dinner
Saturday, Sept 15, 2001
9:00-10:20 SESSION V
Prof. Ralf Baumeister
Genzentrum, Ludwig-Maximilians-Universität, Munich, Germany 
"C.elegans, an Animal Model for the Functional Analysis of Human Disease Genes" 
Prof. Charles Kurland
University of Lund, Sweden 
"Vanishing Genomes, Emergent Proteomes: Evolving Mitochondria" 
Coffee/tea break
10:40-12:00 SESSION VI
Dr. Francois Cambien
Institut National de la Sante et de la Recherche Medicale (INSERM), France 
"Genetics of Multifactorial Diseases" 
Prof. Stylianos E. Antonarakis
Department of Medical Genetics, University of Geneva, Switzerland 
"Chromosome 21; a Small Genomic Land of Fascinating Disorders" 
13:10-14:30 SESSION VII
Prof. Thomas Meitinger
Institute of Human Genetics, Neuherberg, Germany 
"Complexity in Genetic Eye Disease" 
Dr. Massimo Carella, Telethon Institute of Genetics and Medicine (TIGEM), Napoli, Italy 
"The Genetics of Hearing Loss" 
Coffee break
14:50-17:00 SESSION VIII
Dr. Nick Short
Chief Executive Officer, UVS Iceland Genomics Corporation, Iceland 
"Clinical Genomics and the Icelandic Cancer Project" 
Prof. Mart Ustav
Department of Microbiology and Virology, University of Tartu, Estonia 
"Gene Therapy and Gene Vaccination" 
Dr. Priit Kogerman
National Institute of Chemical Physics and Biophysics, Tallinn, Estonia. 
"From Genes to Functions: the Case of CD44" 
Prof. Giovanni Romeo
Director, Unit of Genetic Susceptibility to Cancer, International Agency for Research on Cancer, Lyon, France 
"Genetics of Complex Diseases:the RET Protooncogene and Thyroid Cancer" 
17:00 Closing remarks

Organisers reserve a right to make changes in the provisional programme as required. 

- -
Conference Secretariat: 
 Frens Conference Services, P.O. Box 118, 10502 Tallinn, Estonia
 Ph: +372 6 999 205, fax: +372 6 999 201, e-mail: geneforum@frens.ee